Original language | English |
---|---|
Article number | ALL14340 |
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 75 |
Issue number | 8 |
DOIs |
|
Publication status | Published - 1 Aug 2020 |
Keywords
- allergy diagnosis
- allergy treament
- biomarkers
- clinical immunology
- food allergy
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, No. 8, ALL14340, 01.08.2020.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - EAACI Research and Outreach Committee
T2 - Improving standards and facilitating global collaboration through a Research Excellence Network
AU - Shamji, Mohamed H.
AU - Akdis, Cezmi A.
AU - Barber, Domingo
AU - Canonica, Walter
AU - Chivato, Tomás
AU - del Giacco, Stefano
AU - Hoffman-Sommergruber, Karin
AU - Jutel, Marek
AU - Knol, Edward
AU - Ollert, Markus
AU - O'Mahony, Liam
AU - Palomares, Oscar
AU - Sastre, Joaquin
AU - Schwarze, Jürgen
AU - Smolinska, Sylwia
AU - Vieths, Stefan
AU - Agache, Ioana
N1 - Not indexed in PubMed Funding Information: Dr Vieths reports personal fees from Ärzteverband Deutscher Allergologen, personal fees from Swiss Society for Allergy and Immunology, personal fees from Schattauer Allergologie Handbuch, personal fees from Elsevier Nahrungsmittelallergien und Intoleranzen, personal fees from Karger Food Allergy: Molecular Basis and Clinical Practice, nonfinancial support from German Research Foundation, nonfinancial support from European Directorate for the Quality of Medicines and Health Care, nonfinancial support from European Academy of Allergy and Clinical Immunology, nonfinancial support from German Chemical Society (GDCh), nonfinancial support from AKM Allergiekongress, nonfinancial support from International Union of Immunological Societies, personal fees from Pharmacon, nonfinancial support from Spanish Society for Allergy and Clinical Immunology (SEAIC), outside the submitted work; Dr Jutel reports personal fees from ALK‐Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Circassia, personal fees from Leti, personal fees from Biomay, personal fees from HAL, during the conduct of the study; personal fees from Astra‐Zeneka, personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Vectura, personal fees from UCB, personal fees from Takeda, personal fees from Roche, personal fees from Janssen, personal fees from Medimmune, personal fees from Chiesi, outside the submitted work; Dr Del Giacco has nothing to disclose. Dr Hoffmann‐Sommergruber reports grants from Austrian Science Funds (FWF), grants from EU‐Horion 7, other from EAACI, personal fees from HESI, outside the submitted work; Dr Knol has nothing to disclose. Dr Smolinska has nothing to disclose. Dr Palomares has received research grants from Inmunotek SL, and Novartis Oscar Palomares has received fees for giving scientific lectures from: Allergy Therapeutics, Amgen, AstraZeneca, Diater, GlaxoSmithKline S.A, Inmunotek S.L, Novartis, Sanofi‐Genzyme and Stallergenes Oscar Palomares has participated in advisory boards from Novartis and Sanofi‐Genezyme. Dr Ollert reports personal fees from Hycor Diagnostics, personal fees from Thermo Fisher Scientific, outside the submitted work; Dr O'Mahony reports personal fees from Alimentary Health, grants from GSK, outside the submitted work. Dr BARBER reports personal fees from ALK, personal fees from AIMMUNE, outside the submitted work; Dr CANONICA has nothing to disclose. Dr Schwarze has nothing to disclose. Dr Agache reports and Associate Editor Allergy journal. Dr SASTRE reports grants and personal fees from SANOFI, personal fees from GSK, personal fees from FAES FARMA, personal fees from LETI, personal fees from MUNDIPHARMA, personal fees from NOVARTIS, grants from ALK, outside the submitted work;. Dr Chivato has nothing to disclose. Dr Akdis reports grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine Kühne‐Center for Allergy Research and Education, European Commission's Horison's 2020 Framework Programme, Cure, Novartis Research Institutes, Astra Zeneca, Scibase, advisory role in Sanofi/Regeneron, outside the submitted work. Dr Jutel reports personal fees from ALK‐Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Circassia, personal fees from Leti, personal fees from Biomay, personal fees from HAL, during the conduct of the study; personal fees from Astra‐Zeneka, personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Vectura, personal fees from UCB, personal fees from Takeda, personal fees from Roche, personal fees from Janssen, personal fees from Medimmune, personal fees from Chiesi, outside the submitted work.
PY - 2020/8/1
Y1 - 2020/8/1
KW - allergy diagnosis
KW - allergy treament
KW - biomarkers
KW - clinical immunology
KW - food allergy
UR - http://www.scopus.com/inward/record.url?scp=85085048445&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/32339302
U2 - 10.1111/all.14340
DO - 10.1111/all.14340
M3 - Comment/debate
C2 - 32339302
AN - SCOPUS:85085048445
SN - 0105-4538
VL - 75
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 8
M1 - ALL14340
ER -